Trials / Completed
CompletedNCT03300934
Adolescence and Diabetes:Can an Automated Closed Loop System Improve Control ?
Adolescence and Diabetes: Can an Automated Closed Loop System Improve Control ?
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Centre Hospitalier du Luxembourg · Academic / Other
- Sex
- All
- Age
- 12 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the use of the FD2 automated closed loop insulin administration in Adolescents with a poor metabolic control . All youth will be treated in a random order by their usual pump treatment or an Automated system and we will evaluate whether this has an impact on metabolic control and sleep
Detailed description
Achievement of a good metabolic control is very important for all persons with diabetes . In adolescence many changes occur , physically , socially and psychologically .This may influence the metabolic control . This study will evaluate whether the automated closed-loop will facilitate and improve the management of diabetes in youth with a poor metabolic control. It is a single-centre, randomised, two-period crossover study to assess the efficacy /safety and acceptability of the automated closed-loop glucose control (CL) day and night, over 28 days in comparison with continuous subcutaneous insulin infusion (CSII) in the home setting in poorly controlled type 1 diabetes adolescents.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | closed loop glucose control system | Cross over between Closed loop glucose system with DANA pump, Navigator II CGM and Cambridge AP algorithm FD2A, versus usual CSII pump treatment |
Timeline
- Start date
- 2017-07-01
- Primary completion
- 2018-07-19
- Completion
- 2018-07-19
- First posted
- 2017-10-04
- Last updated
- 2018-07-31
Locations
1 site across 1 country: Luxembourg
Source: ClinicalTrials.gov record NCT03300934. Inclusion in this directory is not an endorsement.